Expression of 5-lipoxygenase in human colorectal cancer (Q33869146)

29 July 2017

Expression of 5-lipoxygenase in human colorectal cancer (English)

1 reference

29 July 2017

1 reference

1 reference

Labile Togba Soumaoro

1

1 reference

29 July 2017

Satoru Iida

2

1 reference

29 July 2017

Hiroyuki Uetake

3

1 reference

29 July 2017

Megumi Ishiguro

4

1 reference

29 July 2017

Yoko Takagi

5

1 reference

29 July 2017

Tetsuro Higuchi

6

1 reference

29 July 2017

Masamichi Yasuno

7

1 reference

29 July 2017

Masayuki Enomoto

8

1 reference

29 July 2017

Kenichi Sugihara

9

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

World Journal of Gastroenterology

29 July 2017

1 reference

29 July 2017

12

1 reference

29 July 2017

39

1 reference

29 July 2017

6355-6360

1 reference

5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Selective COX-2 inhibitors and risk of myocardial infarction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

The role of prostaglandins and other eicosanoids in the gastrointestinal tract

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Prognostic value of ERM gene expression in human primary breast cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Lipoxygenase inhibitors prevent urological cancer cell growth

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

New trends in dual 5-LOX/COX inhibition

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Many actions of cyclooxygenase-2 in cellular dynamics and in cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Lipoxygenase-5 is overexpressed in prostate adenocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Lipoxygenase inhibitors as potential cancer chemopreventives

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Expression of 15-lipoxygenase-1 in human colorectal cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Mammalian lipoxygenases: molecular structures and functions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6355

Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6355

Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6355

Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6355

Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6355

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6355

Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6355

Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I39.6355

Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088146

Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia

29 October 2018

1 reference

12 December 2020

Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors

1 reference

12 December 2020

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

1 reference

12 December 2020

Cyclooxygenase-1 and -2 in human testicular tumours

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I39.6355

1 reference

29 July 2017

1 reference

29 July 2017

1 reference